id	author	title	date	pages	extension	mime	words	sentences	flesch	summary	cache	txt
cord-262159-8y0q45gr	Ciorba, Andrea	Don’t forget ototoxicity during the SARS-CoV-2 (Covid-19) pandemic!	2020-07-10		.txt	text/plain	956	59	41	Aim of this communication is to remind clinical professionals to be aware of ototoxic side effects of several specific drugs proposed for the treatment of the new virus SARS-CoV-2 (Covid-19). In particular, chloroquine and hydroxychloroquine have been widely promoted and used during the pandemic; 2,3 however, in the past, data in the literature have suggested that in many treated cases side effects such as sensorineural hearing loss, tinnitus, and/or persistent imbalance were common. However, ototoxicity has been reported among the possible side effects of the adenosine nucleotide analogues; 5, 6 specifically, data in the literature report that patients may develop irreversible unilateral or bilateral hearing loss and tinnitus due to the use of these drugs, usually after a few weeks of administration. 7, 8 Lopinavir, a nucleoside reverse-transcriptase inhibitor, proposed in the treatment of SARS-CoV-2 infections, has been related to the onset of sensorineural hearing loss, 9 after several weeks of administration.	./cache/cord-262159-8y0q45gr.txt	./txt/cord-262159-8y0q45gr.txt